@article{groheux_performance_2013,
	title = {Performance of {FDG} {PET}/{CT} in the clinical management of breast cancer},
	volume = {266},
	issn = {1527-1315},
	shorttitle = {Performance of {FDG} {PET}/{CT} in the clinical management of breast cancer},
	url = {http://dx.doi.org/10.1148/radiol.12110853},
	abstract = {In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art positron emission tomography (PET)/computed tomography (CT) technology. The strengths and limitations of FDG PET/CT are examined in various clinical settings, and the following questions are answered: Is FDG PET/CT useful to differentiate malignant from benign breast lesions? Can FDG PET/CT replace sentinel node biopsy for axillary staging? What is the role of FDG PET/CT in initial staging of inflammatory or locally advanced breast cancer? What is the role of FDG PET/CT in initial staging of clinical stage IIA and IIB and primary operable stage IIIA breast cancer? How does FDG PET/CT compare with conventional techniques in the restaging of cancer in patients who are suspected of having disease recurrence? What is the role of FDG PET/CT in the assessment of early response to neoadjuvant therapy and of response to therapy for metastatic disease? Some recommendations for clinical practice are given.},
	number = {2},
	journal = {Radiology},
	author = {Groheux, David and Espié, Marc and Giacchetti, Sylvie and Hindié, Elif},
	year = {2013},
	pages = {388--405},
}

{"_id":"9QbcRgyBPnp5kNcsd","bibbaseid":"groheux-espi-giacchetti-hindi-performanceoffdgpetctintheclinicalmanagementofbreastcancer-2013","author_short":["Groheux, D.","Espié, M.","Giacchetti, S.","Hindié, E."],"bibdata":{"bibtype":"article","type":"article","title":"Performance of FDG PET/CT in the clinical management of breast cancer","volume":"266","issn":"1527-1315","shorttitle":"Performance of FDG PET/CT in the clinical management of breast cancer","url":"http://dx.doi.org/10.1148/radiol.12110853","abstract":"In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art positron emission tomography (PET)/computed tomography (CT) technology. The strengths and limitations of FDG PET/CT are examined in various clinical settings, and the following questions are answered: Is FDG PET/CT useful to differentiate malignant from benign breast lesions? Can FDG PET/CT replace sentinel node biopsy for axillary staging? What is the role of FDG PET/CT in initial staging of inflammatory or locally advanced breast cancer? What is the role of FDG PET/CT in initial staging of clinical stage IIA and IIB and primary operable stage IIIA breast cancer? How does FDG PET/CT compare with conventional techniques in the restaging of cancer in patients who are suspected of having disease recurrence? What is the role of FDG PET/CT in the assessment of early response to neoadjuvant therapy and of response to therapy for metastatic disease? Some recommendations for clinical practice are given.","number":"2","journal":"Radiology","author":[{"propositions":[],"lastnames":["Groheux"],"firstnames":["David"],"suffixes":[]},{"propositions":[],"lastnames":["Espié"],"firstnames":["Marc"],"suffixes":[]},{"propositions":[],"lastnames":["Giacchetti"],"firstnames":["Sylvie"],"suffixes":[]},{"propositions":[],"lastnames":["Hindié"],"firstnames":["Elif"],"suffixes":[]}],"year":"2013","pages":"388–405","bibtex":"@article{groheux_performance_2013,\n\ttitle = {Performance of {FDG} {PET}/{CT} in the clinical management of breast cancer},\n\tvolume = {266},\n\tissn = {1527-1315},\n\tshorttitle = {Performance of {FDG} {PET}/{CT} in the clinical management of breast cancer},\n\turl = {http://dx.doi.org/10.1148/radiol.12110853},\n\tabstract = {In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art positron emission tomography (PET)/computed tomography (CT) technology. The strengths and limitations of FDG PET/CT are examined in various clinical settings, and the following questions are answered: Is FDG PET/CT useful to differentiate malignant from benign breast lesions? Can FDG PET/CT replace sentinel node biopsy for axillary staging? What is the role of FDG PET/CT in initial staging of inflammatory or locally advanced breast cancer? What is the role of FDG PET/CT in initial staging of clinical stage IIA and IIB and primary operable stage IIIA breast cancer? How does FDG PET/CT compare with conventional techniques in the restaging of cancer in patients who are suspected of having disease recurrence? What is the role of FDG PET/CT in the assessment of early response to neoadjuvant therapy and of response to therapy for metastatic disease? Some recommendations for clinical practice are given.},\n\tnumber = {2},\n\tjournal = {Radiology},\n\tauthor = {Groheux, David and Espié, Marc and Giacchetti, Sylvie and Hindié, Elif},\n\tyear = {2013},\n\tpages = {388--405},\n}\n\n\n\n","author_short":["Groheux, D.","Espié, M.","Giacchetti, S.","Hindié, E."],"key":"groheux_performance_2013","id":"groheux_performance_2013","bibbaseid":"groheux-espi-giacchetti-hindi-performanceoffdgpetctintheclinicalmanagementofbreastcancer-2013","role":"author","urls":{"Paper":"http://dx.doi.org/10.1148/radiol.12110853"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"http://bibbase.org/zotero/biblioial","dataSources":["ftoP3zPyb2N3b9Noc"],"keywords":[],"search_terms":["performance","fdg","pet","clinical","management","breast","cancer","groheux","espié","giacchetti","hindié"],"title":"Performance of FDG PET/CT in the clinical management of breast cancer","year":2013}